Kayothera
PrivateLast Round
Grant
Jul 19, 2023
Total Funding Raised
$13.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kayothera is a biotechnology company that develops first-in-class, oral, small-molecule inhibitors of the retinoid nuclear receptor pathway for the treatment of cancer and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayothera Comparables
Compare Kayothera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Io Therapeutics, Inc. | 82% | |
| Orphagen Pharmaceuticals | 82% | |
| Forkhead Biotherapeutics, Inc. | 73% |
Kayothera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 19, 2023 | ||||
| Series A Extension | Jul 19, 2023 | ||||
| Series A | Mar 16, 2022 | ||||
| Seed | Aug 12, 2019 | ||||
| Seed | Mar 28, 2018 |
Key People
Founding team and executive leadership
Kayothera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerator Life Science Partners | Series A, Series A Extension |
| Foundation Venture Capital Group | Seed |
| New Jersey Health Foundation | Seed |
| NIH RADx | Series A Extension, Grant |
| WRF Capital | Series A Extension |
| Washington Research Foundation Capital | Series A Extension |
| Pier 70 Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 384% MoM, from 552 to 2.7K.
- Apr 18, 2026
Monthly visitors increased 108% MoM, reaching 1.7K.
Kayothera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kayothera's valuation, stock price, and market status.
Is Kayothera a public or private company?
Kayothera is a private company.
What is the current stock price of Kayothera?
Kayothera is a private company with no public stock price. No recent secondary market data is available.
How much is Kayothera worth (valuation)?
Valuation information for Kayothera is not publicly available.
Can I buy Kayothera stock?
Kayothera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kayothera's last funding round?
Kayothera's most recent funding round was Series A Extension on July 19, 2023.
Who are the main investors in Kayothera?
Key investors in Kayothera include Accelerator Life Science Partners, New Jersey Health Foundation.
Will Kayothera IPO soon?
No public IPO plans have been announced for Kayothera.
How can I track Kayothera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kayothera's secondary market activity and sign up for updates.